BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cytiva and Pall Life Sciences merge to form a comprehensive solutions provider for biotechnology challenges, with focus on innovation and digitalization

Discover how the combined technical expertise, talent, and portfolio offerings of these two distinguished brands are driving the next generation of medicin...

May 12, 2023 | News

Revolutionizing Drug Development: IQVIA's David Cameron on the Power of Innovative Trial Designs

Can you tell us about your role as Senior Director & Global Head of Novel Trial Design at IQVIA? The Novel Trial Design initiative at IQ...

May 09, 2023 | News

Beyond Automation: Improving Efficiency, Sustainability and Reliability Using Clean-in-Place and Steam-in-Place In-Depth Analytics

Drug manufacturers use clean-in-place (CIP) and steam-in-place (SIP) systems to internally clean equipment between batches to ensure produc...

April 21, 2023 | Opinion | By Jennifer Williams, Product Marketing Manager, Discrete Automation at Emerson www.emerson.com

Pharma marketing future and present: AI & Modular Content in APAC focus

At the same time, it is crucial to understand that the implementation of AI and ML technologies requires eradicative change within the whole company struct...

March 31, 2023 | News

Aptamer Group's Optimer-Fc: An Innovative Solution to Enhance Accuracy of Automated IHC Workflows

Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...

March 29, 2023 | Influencers

Eppendorf's commitment to customer-centric innovation: How the company stays ahead of the curve

BioPharma APAC organized a Women’s Leadership Series and interviewed a Eva van Pelt Co-CEO & Chief Commercial Officer Eppendorf SE, Hamburg, Germ...

March 21, 2023 | News

STADA builds on Movapo heritage to offer Australian Parkinson’s patients new option

Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...

February 13, 2023 | News

GenScript is increasing its capacity for producing cGMP sgRNA and non-viral DNA payloads in order to keep project wait times to a minimum.

How is GenScript planning to meet the growing demand for cell and gene therapies in 2023? GenScript is committed to advancing non-viral gene and cell ther...

February 01, 2023 | Influencers

Aptamer Group’s discovery platform is enabling new solutions across the life sciences.

How is success in the discovery of small molecule ligands increased with the Optimer platform? The Optimer platform incorporates three se...

January 04, 2023 | News

Helping to maintain the pace of innovation with aptamers

Part of this change in approach has led to an increased interest in aptamer technology in place of traditional antibodies. Like antibodies, aptamers can be...

December 12, 2022 | Analysis

Why Pharma and Medtech Should Digitize Quality in a Down Market

We tend to put off investments in improvements and instead opt to play it safe, taking a conservative approach to weathering the economic storm. For ...

November 01, 2022 | News | By Michelle Tanner, CFO, MasterControl

Looking ahead, it is important that we glean the lessons learned from the pandemic and apply them in our current and future plans to help improve our efforts towards ending the HIV epidemic : Dustin Haines

Q1. What emerging trends are shaping the future of research in Virology? This is an extraordinary time in which infectious disease research ...

October 25, 2022 | Influencers

CureLab to address the growing burden of cancer in APAC : Dr. Alexander Shneider

Dr. Shneider is the CEO of CureLab Oncology, bringing more than 25 years of biotech and entrepreneurial experience. He is currently a senior resear...

October 17, 2022 | News

Modernizing Your Way to Success in Cell & Gene Therapy Manufacturing

There are now 1,300 companies actively involved in cell and gene therapy manufacturing1 and 11 gene therapy medicinal products with valid marketi...

October 07, 2022 | Opinion | By By James Jardine, GxP Lifeline Editor, MasterControl

Stay Connected